Literature DB >> 28579443

Value-Based pricing and the end of pharmaceutical pricing as we know it? A case study on sorafenib and axitinib.

Panagiotis Petrou1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28579443     DOI： 10.1016/j.phrs.2017.05.012

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN： 1043-6618            Impact factor:   7.658


× No keyword cloud information.
  1 in total

1.  A novel long-sustaining system of apatinib for long-term inhibition of the proliferation of hepatocellular carcinoma cells.

Authors:  Yanli Wang; Zigui Tang
Journal:  Onco Targets Ther       Date:  2018-11-29       Impact factor: 4.147
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.